These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 23362306)
1. Reduction of indoxyl sulfate by AST-120 attenuates monocyte inflammation related to chronic kidney disease. Ito S; Higuchi Y; Yagi Y; Nishijima F; Yamato H; Ishii H; Osaka M; Yoshida M J Leukoc Biol; 2013 Jun; 93(6):837-45. PubMed ID: 23362306 [TBL] [Abstract][Full Text] [Related]
2. Oral adsorbent AST-120 ameliorates endothelial dysfunction independent of renal function in rats with subtotal nephrectomy. Namikoshi T; Tomita N; Satoh M; Sakuta T; Kuwabara A; Kobayashi S; Higuchi Y; Nishijima F; Kashihara N Hypertens Res; 2009 Mar; 32(3):194-200. PubMed ID: 19262482 [TBL] [Abstract][Full Text] [Related]
3. Role of oxidative stress and indoxyl sulfate in progression of cardiovascular disease in chronic kidney disease. Fujii H; Nakai K; Fukagawa M Ther Apher Dial; 2011 Apr; 15(2):125-8. PubMed ID: 21426501 [TBL] [Abstract][Full Text] [Related]
4. Indoxyl Sulfate Contributes to Adipose Tissue Inflammation through the Activation of NADPH Oxidase. Tanaka S; Watanabe H; Nakano T; Imafuku T; Kato H; Tokumaru K; Arimura N; Enoki Y; Maeda H; Tanaka M; Matsushita K; Fukagawa M; Maruyama T Toxins (Basel); 2020 Aug; 12(8):. PubMed ID: 32764271 [TBL] [Abstract][Full Text] [Related]
5. Deleterious vascular effects of indoxyl sulfate and reversal by oral adsorbent AST-120. Six I; Gross P; Rémond MC; Chillon JM; Poirot S; Drueke TB; Massy ZA Atherosclerosis; 2015 Nov; 243(1):248-56. PubMed ID: 26408929 [TBL] [Abstract][Full Text] [Related]
6. AST-120 ameliorates lowered exercise capacity and mitochondrial biogenesis in the skeletal muscle from mice with chronic kidney disease via reducing oxidative stress. Nishikawa M; Ishimori N; Takada S; Saito A; Kadoguchi T; Furihata T; Fukushima A; Matsushima S; Yokota T; Kinugawa S; Tsutsui H Nephrol Dial Transplant; 2015 Jun; 30(6):934-42. PubMed ID: 25878055 [TBL] [Abstract][Full Text] [Related]
7. Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease. Kamiński TW; Pawlak K; Karbowska M; Myśliwiec M; Pawlak D BMC Nephrol; 2017 Jan; 18(1):35. PubMed ID: 28122514 [TBL] [Abstract][Full Text] [Related]
8. Editorial: A missing link? Monocyte activation by uremic toxins in cardiorenal syndrome. Armstrong EJ; Granick JL; Simon SI J Leukoc Biol; 2013 Jun; 93(6):821-3. PubMed ID: 23723377 [No Abstract] [Full Text] [Related]
9. Role of indoxyl sulfate in the progression of chronic kidney disease and cardiovascular disease: experimental and clinical effects of oral sorbent AST-120. Niwa T Ther Apher Dial; 2011 Apr; 15(2):120-4. PubMed ID: 21426500 [TBL] [Abstract][Full Text] [Related]
10. Amelioration of uremic toxin indoxyl sulfate-induced endothelial cell dysfunction by Klotho protein. Yang K; Nie L; Huang Y; Zhang J; Xiao T; Guan X; Zhao J Toxicol Lett; 2012 Nov; 215(2):77-83. PubMed ID: 23085347 [TBL] [Abstract][Full Text] [Related]
11. Possible involvement of nuclear factor-kappaB inhibition in the renal protective effect of oral adsorbent AST-120 in a rat model of chronic renal failure. Komiya T; Miura K; Tsukamoto J; Okamura M; Tamada S; Asai T; Tashiro K; Kuwabara N; Iwao H; Yoshikawa J Int J Mol Med; 2004 Jan; 13(1):133-8. PubMed ID: 14654984 [TBL] [Abstract][Full Text] [Related]
12. Indoxyl sulfate enhances IL-1β-induced E-selectin expression in endothelial cells in acute kidney injury by the ROS/MAPKs/NFκB/AP-1 pathway. Shen WC; Liang CJ; Huang TM; Liu CW; Wang SH; Young GH; Tsai JS; Tseng YC; Peng YS; Wu VC; Chen YL Arch Toxicol; 2016 Nov; 90(11):2779-2792. PubMed ID: 26659566 [TBL] [Abstract][Full Text] [Related]
13. Indoxyl sulfate is a nephro-vascular toxin. Niwa T J Ren Nutr; 2010 Sep; 20(5 Suppl):S2-6. PubMed ID: 20797565 [TBL] [Abstract][Full Text] [Related]
14. C-reactive protein promotes adhesion of monocytes to endothelial cells via NADPH oxidase-mediated oxidative stress. Huang X; Zhang J; Liu J; Sun L; Zhao H; Lu Y; Wang J; Li J J Cell Biochem; 2012 Mar; 113(3):857-67. PubMed ID: 22020763 [TBL] [Abstract][Full Text] [Related]
15. Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress induces monocyte adhesion by stimulating reactive oxygen species production from a nox1-based NADPH oxidase. Sorescu GP; Song H; Tressel SL; Hwang J; Dikalov S; Smith DA; Boyd NL; Platt MO; Lassègue B; Griendling KK; Jo H Circ Res; 2004 Oct; 95(8):773-9. PubMed ID: 15388638 [TBL] [Abstract][Full Text] [Related]
16. Indoxyl sulfate induces intestinal barrier injury through IRF1-DRP1 axis-mediated mitophagy impairment. Huang Y; Zhou J; Wang S; Xiong J; Chen Y; Liu Y; Xiao T; Li Y; He T; Li Y; Bi X; Yang K; Han W; Qiao Y; Yu Y; Zhao J Theranostics; 2020; 10(16):7384-7400. PubMed ID: 32641998 [No Abstract] [Full Text] [Related]
17. Angiotensin-converting enzyme inhibitor attenuates monocyte adhesion to vascular endothelium through modulation of intracellular zinc. Kojima C; Kawakami A; Takei T; Nitta K; Yoshida M J Pharmacol Exp Ther; 2007 Dec; 323(3):855-60. PubMed ID: 17878405 [TBL] [Abstract][Full Text] [Related]
18. An oral adsorbent, AST-120, suppresses oxidative stress in uremic rats. Nakagawa N; Hasebe N; Sumitomo K; Fujino T; Fukuzawa J; Hirayama T; Kikuchi K Am J Nephrol; 2006; 26(5):455-61. PubMed ID: 17057375 [TBL] [Abstract][Full Text] [Related]
19. The role of carbon adsorbent in the conservative management of chronic kidney disease. Niwa T Panminerva Med; 2017 Jun; 59(2):139-148. PubMed ID: 27990791 [TBL] [Abstract][Full Text] [Related]
20. High glucose condition increases NADPH oxidase activity in endothelial microparticles that promote vascular inflammation. Jansen F; Yang X; Franklin BS; Hoelscher M; Schmitz T; Bedorf J; Nickenig G; Werner N Cardiovasc Res; 2013 Apr; 98(1):94-106. PubMed ID: 23341580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]